Cirius Therapeutics Competitors and Similar CompaniesClear all
Cirius Therapeutics's competitors and similar companies include CSL Behring, Ipsen, Livzon Pharmaceutical Group and Chiesi Group.
 Cirius Therapeutics Cirius Therapeutics, a clinical-stage pharmaceutical company which is developing a next-generation insulin sensitizer for the treatment of nonalcoholic steatohepatitis. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | |||
Founding Date | Founding Date 2016 | Founding Date 1904 | Founding Date 1929 | Founding Date 1985 | Founding Date 1935 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Kalamazoo, US HQ San Diego, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees N/A | Employees 7,5692% decrease | Employees 5,358 | Employees 9,067 | Employees 5,8541% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) €2.4b (Y, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit €3.3b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income €445.1m (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Trademark Applications | Trademark Applications N/A | Trademark Applications 1 (Dec, 2020) | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) | Trademark Applications N/A |
Trademarks | Trademarks N/A | Trademarks 4 (Dec, 2020) | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks N/A |
For sources of this data, please see the company profile
View Company Profiles
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View company